Structure Therapeutics: A Modest Proposal

Rock Springs, it seems, decided to take a bit of profit off the table. A sensible precaution, one might argue, when a stock has tripled in value over a year. It’s akin to a seasoned gambler pocketing a portion of his winnings before the roulette wheel spins again. They retain a respectable 748,236 shares, valued at $52.04 million, but have slipped from the fund’s inner circle – the top five holdings, where the truly serious money resides. A demotion, if you will, though one suspects Structure Therapeutics won’t be sending a condolence letter.







